Randomized Controlled Trial of Big Brothers Big Sisters Mentoring for Prevention of Crime and Del… (NCT03495635) | Clinical Trial Compass
CompletedNot Applicable
Randomized Controlled Trial of Big Brothers Big Sisters Mentoring for Prevention of Crime and Delinquency
United States1,361 participantsStarted 2018-02-02
Plain-language summary
The purpose of this study is to evaluate the effectiveness of the Big Brothers Big Sisters of America (BBBSA) community-based mentoring (CBM) program for prevention of crime and delinquency/conduct problems, including risk and protective factors for these outcomes. Approximately 2,500 youth ages 10-16 will be randomly assigned to either the CBM program or an untreated control group. Study outcomes will be assessed over a 4-year period via both youth- and parent-report surveys and official records of police/court contact (e.g., arrests).
Who can participate
Age range
10 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria:
* youth is 10 years of age or older
* youth is likely to be eligible for the Big Brothers Big Sisters Community-Based Mentoring program as determined by initial assessment of program staff
Exclusion criteria:
* youth has a severe learning, cognitive or other intellectual disability as reported by the parent
* parent does not both speak and read either English or Spanish
* youth does not have a sibling who is already a study participant
* youth has been matched with a Big Brother/Sister through one of the affiliate's programs in the past
* youth has a sibling currently receiving services from the affiliate for whom services were initiated (i.e., inquiry was made) prior to start of the study
* youth belongs to a group that the affiliate is excluding from study participation based on previous agreement with the research team
* youth is designated as an exception case by affiliate staff (each affiliate will have the opportunity to exclude up to 4% of study-eligible youth from the research prior to consent and random assignment for any reason deemed appropriate (e.g., perceived high need of the youth))
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.